BioSyent Inc. (BIOYF) Financials
BIOYF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 30.5 million | 5.0 million |
| 2023-06-30 | 29.8 million | 4.9 million |
| 2023-03-31 | 28.6 million | 3.9 million |
| 2022-12-31 | 29.9 million | 5.3 million |
BIOYF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | 1.8 million | 98716 |
| 2023-06-30 | 2.3 million | 94180 |
| 2023-03-31 | -882780 | 87229 |
| 2022-12-31 | 1.4 million | 91156 |
BIOYF Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | 1.7 million |
| 2023-06-30 | 1.1 million |
| 2023-03-31 | 868678 |
| 2022-12-31 | 884592 |
BIOYF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 21.6 million | - | 930995 |
| 2023-06-30 | 21.1 million | - | 988756 |
| 2023-03-31 | 19.4 million | - | 999467 |
| 2022-12-31 | 21.2 million | - | 1.0 million |
BIOYF Shares Outstanding
BIOYF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 13301 | 20085 | 1.9 million | 1.2 million |
| 2023-06-30 | 5881 | 28234 | 2.0 million | 1.4 million |
| 2023-03-31 | 70973 | 27839 | 1.6 million | 1.1 million |
| 2022-12-31 | 210722 | 67675 | 1.8 million | 1.6 million |
BIOYF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 6.5 million | 1.3 million |
| 2023-06-30 | 6.0 million | 1.1 million |
| 2023-03-31 | 4.8 million | 848511 |
| 2022-12-31 | 5.5 million | 935334 |
BIOYF
Price: $6.49
Dividend Yield: 1.86%
Forward Dividend Yield: 1.85%
Payout Ratio: 30.95%
Dividend Per Share: 0.12 USD
Earnings Per Share: 0.38 USD
P/E Ratio: 16.82
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 75.5 million
Average Dividend Frequency: 4
Years Paying Dividends: 2